ACADIA Pharmaceuticals ACAD
$ 16.61
-0.75%
Quarterly report 2023-Q1
added 05-08-2023
Country |
USA |
IPO year |
2004 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Stephen Davis |
Employees in the company |
580 |
Shares |
160 M |
Market Cap[1] |
$ 2.67 B |
EBITDA (LTM) |
$ -213 M |
P/E (LTM) |
-14.86 |
P/S (LTM) |
7.0 |
EPS (LTM) |
-1.45 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.